Editorial for the Special Issue “Research on Radiotracers and Novel Radiopharmaceuticals for Cancer Therapy and Diagnosis”
Antonio Shegani · 2026
Read Editorial for the Special Issue “Research on Radiotracers and Novel Radiopharmaceuticals for Cancer Therapy and Diagnosis” by Antonio Shegani (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13305968.txt.
Description
Antonio Shegani introduces a 2026 special issue devoted to radioactive tracers and radiopharmaceuticals for cancer care. Tracers can reveal disease biology inside the body, guide treatment choices, and show whether a drug target is present across tumours. Paired diagnosis and therapy, known as theranostics, frames much of the collection.
Contributions span peptide probes for PET scanning, SPECT agents that profile receptors, and chemical tweaks that keep radioligands stable longer. One highlighted study labelled a peptide with gallium-68 to image blood-vessel receptors in breast cancer. Another measured HER2 levels with a technetium-labelled scaffold protein. Shegani presents the issue as a map of where tracer design, preclinical testing, and clinical translation currently stand.
Catalog record
| CREATOR | Antonio Shegani |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 8 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |